168 related articles for article (PubMed ID: 3924533)
21. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Comparison with cimetidine and sucralfate.
Stiel D; Ellard KT; Hills LJ; Brooks PM
Am J Med; 1986 Aug; 81(2A):54-8. PubMed ID: 3092656
[TBL] [Abstract][Full Text] [Related]
22. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man.
Konturek SJ; Kwiecień N; Obtułowicz W; Kopp B; Oleksy J
Gut; 1986 Dec; 27(12):1450-6. PubMed ID: 3492413
[TBL] [Abstract][Full Text] [Related]
23. Reduction of aspirin-induced gastrointestinal bleeding with cimetidine.
Welch RW; Bentch HL; Harris SC
Gastroenterology; 1978 Feb; 74(2 Pt 2):459-63. PubMed ID: 340334
[TBL] [Abstract][Full Text] [Related]
24. [Prostaglandin E1 (misoprostol) and S-adenosylmethionine in the prevention of hemorrhagic gastritis induced by aspirin in the human. Endoscopic, histologic and histochemical study].
Laudanno OM; Finkelstein D; Capdepon E
Acta Gastroenterol Latinoam; 1984; 14(4):289-93. PubMed ID: 6399655
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal blood loss of oxaprozin and aspirin with placebo control.
Lussier A; LeBel E; Tétreault L
J Clin Pharmacol; 1982 Apr; 22(4):173-8. PubMed ID: 6980231
[TBL] [Abstract][Full Text] [Related]
26. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Taha AS; McCloskey C; McSkimming P; McConnachie A
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
[TBL] [Abstract][Full Text] [Related]
27. Acetylsalicylic acid and gastrointestinal bleeding measurement of blood loss using a modified radioactive chromium method.
Arvidsson B; Magnusson B; Sölvell ; Magnusson A
Scand J Gastroenterol; 1975; 10(2):155-60. PubMed ID: 1091965
[TBL] [Abstract][Full Text] [Related]
28. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
Silverstein FE; Kimmey MB; Saunders DR; Levine DS
Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
[TBL] [Abstract][Full Text] [Related]
29. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
Roth S; Agrawal N; Mahowald M; Montoya H; Robbins D; Miller S; Nutting E; Woods E; Crager M; Nissen C
Arch Intern Med; 1989 Apr; 149(4):775-9. PubMed ID: 2495779
[TBL] [Abstract][Full Text] [Related]
30. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
31. Protection against aspirin-induced antral and duodenal damage with enprostil. A double-blind endoscopic study.
Cohen MM; McCready DR; Clark L; Sevelius H
Gastroenterology; 1985 Jan; 88(1 Pt 2):382-6. PubMed ID: 3917264
[TBL] [Abstract][Full Text] [Related]
32. Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone.
Lussier A; LeBel E
Am J Med; 1987 Oct; 83(4B):15-8. PubMed ID: 3500642
[TBL] [Abstract][Full Text] [Related]
33. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
34. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ
Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050
[TBL] [Abstract][Full Text] [Related]
35. Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding.
Kyaw MH; Otani K; Ching JYL; Higashimori A; Kee KM; Watanabe T; Tse YK; Lee V; Tanigawa T; Cheong PK; Suen BY; Fujiwara Y; Lam K; Arakawa T; Chan FKL
Gastroenterology; 2018 Oct; 155(4):1090-1097.e1. PubMed ID: 29966612
[TBL] [Abstract][Full Text] [Related]
36. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
Delmas PD; Lambert R; Capron MH
Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
[TBL] [Abstract][Full Text] [Related]
37. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
38. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ
Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645
[TBL] [Abstract][Full Text] [Related]
39. A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma.
Wasiak W; Szmidt M
Thorax; 1999 Oct; 54(10):900-4. PubMed ID: 10491452
[TBL] [Abstract][Full Text] [Related]
40. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.
Gullikson GW; Anglin CP; Kessler LK; Smeach S; Bauer RF; Dajani EZ
Clin Invest Med; 1987 May; 10(3):145-51. PubMed ID: 3113798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
